PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece
Abstract
Authors
G. Gourzoulidis O. Zisimopoulou N. Boubouchairopoulou C. Michailidi C. Almond C. Tzanetakos G. Kourlaba